#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchiectasis Hodgkin's disease recurrent Cardiac sarcoidosis Polyneuropathy Acute on chronic liver failure Von Hippel-Lindau disease Postprandial hypoglycaemia Chronic lymphocytic leukaemia refractory Retinal dystrophy Small intestine adenocarcinoma Dupuytren's contracture Arrhythmogenic right ventricular dysplasia Hepatoblastoma Eosinophilic granulomatosis with polyangiitis Gastrointestinal disorder More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Treatment Tuberous sclerosis complex – Life with Disease Angelman’s syndrome – Life with Disease Haemolytic uraemic syndrome – Diagnostics Mitochondrial myopathy – Diagnostics Stevens-Johnson syndrome – Basic Information Primary hyperoxaluria – Diagnostics Congenital nephrogenic diabetes insipidus Familial haemophagocytic lymphohistiocytosis – Trials in Disease Short-bowel syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Hydroxide Soticlestat Zofenopril Calcium Eo2318 Edg-5506 Englumafusp Alfa Abc-35B-116 ABIRATERONE DECANOATE Ropivacaine Ademetionine Etrinabdione Molidustat Sodium Hydroxypropyl Cellulose Lf Ciprofloxacin Hydrochloride Minocycline Absk021 Hydrochloride Hydrate Sibeprenlimab Ly3298176 Oxymetazoline Hydrochloride Batoprotafib More therapies…

    Learn about Your Condition

    Lymphangiosarcoma Behavioural addiction Decreased appetite Thyroidectomy Primary biliary cholangitis Vertigo Heart disease congenital Hodgkin's disease Rhabdoid tumour Respiratory tract infection Peptostreptococcus infection Melanoma recurrent Perinatal depression Juvenile spondyloarthritis Anal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Piperacillin and Tazobactam Given Under the Skin Compared to a Vein in Patients with Infectious Diseases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Piperacillin
    • Tazobactam
    Italy

  • A Study of Valemetostat Tosylate in Adult Patients with Advanced Solid Tumors That Have Specific Gene Changes or Are Clear Cell Endometrial or Ovarian Cancers

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Valemetostat Tosilate
    France

  • Study of bilastine for effectiveness, safety and quality of life in children aged 6 to 12 years with allergic rhinoconjunctivitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Bilastine
    Italy Poland Spain

  • A Study of Atumelnant for Children with Congenital Adrenal Hyperplasia

    Recruiting

    4 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • ATUMELNANT
    Belgium France Germany Italy The Netherlands Poland

  • A Study Testing the Safety and How Well GTX-102 Works in Adults and Children with Angelman Syndrome

    Recruiting

    2 1 1
    Investigated Drugs:
    • DISODIUM PHOSPHATE
    • Sodium Dihydrogen Phosphate Dihydrate
    • APAZUNERSEN
    France Italy Portugal

  • Study of Trastuzumab Deruxtecan Versus Chemotherapy as Additional Treatment After Surgery for Patients with HER2-Positive Endometrial Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Docetaxel
    France Germany Greece Italy Poland Portugal +1
Previous Page
1 … 65 66 67 68 69 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!